The Medicalization of Bereavement: (Ab)normal Grief in the DSM-5
The Medicalization of Bereavement: (Ab)normal Grief in the DSM-5
复制标题
DOI：
10.1080/07481187.2014.951498
复制
发表时间：
2015-01-01
期刊：
影响因子：
3.8
通讯作者：
Bandini, Julia
中科院分区：
文献类型：
--
作者：
Bandini, Julia
本文探讨了最近发布的更改，以消除第五版诊断和统计手册 (DSM-5) 重度抑郁症诊断标准中的丧亲排除 (BE)。许多学者和批评家表示担忧，称这些变化是悲伤的医疗化。本文首先考虑消除BE，然后研究这种悲伤医疗化的宏观和微观后果，包括过度诊断和过度治疗、制药公司潜在的扩大市场，以及适应失去亲人的传统和文化方法的丧失。
This article examines the recently published changes to eliminate the bereavement exclusion (BE) from the criteria for the diagnosis of major depression in the fifth edition of the Diagnostic and Statistical Manual (DSM-5). Numerous scholars and critics have expressed concerns by calling these changes a medicalization of grief. This article first considers the removal of the BE and then examines the macrolevel and microlevel consequences of this medicalization of grief, including overdiagnosis and overtreatment, a potential expanded market for pharmaceutical companies, and the loss of traditional and cultural methods of adapting to the loss of a loved one.